BioCentury
ARTICLE | Clinical News

Tumor vaccine technology regulatory update

February 5, 2001 8:00 AM UTC

MDG received U.S. Patent No. 6,171,595 covering the use of adeno-associated virus (AAV) to deliver immunostimulatory genes to tumor cells. MDG and partner Aventis S.A. (AVE, Strasbourg, France) are u...